You are here
MDMA and psilocybin hub
Find out how to prescribe or get access to MDMA or psilocybin.
On this page
Authorised psychiatrists can access products containing 3,4‑methylenedioxy‑methamphetamine (MDMA) or psilocybin for specific mental health conditions from 1 July 2023.
MDMA can be used for the treatment of post-traumatic stress disorder.
Psilocybin can be used for treatment-resistant depression.
To access products containing MDMA or psilocybin, you must be a registered psychiatrist approved under the TGA's Authorised Prescriber scheme.
- Access MDMA or psilocybin (consumers)PageMDMA can be accessed to treat post-traumatic stress disorder (PTSD). Psilocybin can be accessed for treatment-resistant depression (TRD).
- Prescribe MDMA or psilocybin (psychiatrists)PageClinical resources and guidance on accessing MDMA and psilocybin under the Authorised Prescriber scheme.
- Dispense or compound MDMA and psilocybin (pharmacists)PageInformation for pharmacists on dispensing, supplying and compounding MDMA and psilocybin.
- Supply, manufacture or import MDMA or psilocybin (sponsors and manufacturers)PageInformation for Australian sponsors on manufacturing, supplying and importing MDMA and psilocybin.
Topics